First-pass extracted concept

ocular neurovascular system

Candidate: concept label1 source documents5 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Aliases

neurovascular system in the eye

Extracted Explainers

What the tool is doing

The review centers the eye's neurovascular system as a key framework for understanding aging-related retinal and optic disease.

Source 1DOI PubMed

What problem it solves

It provides an organizing concept linking vascular injury, barrier dysfunction, and neuronal loss across multiple eye diseases.

Source 1DOI PubMed

What it does not solve

The abstract does not define a discrete engineered tool or intervention based on this concept.

Source 1DOI PubMed

Alternatives

The abstract contrasts no explicit alternative framework, but also discusses disease-specific views in glaucoma, AMD, and AD.

Source 1DOI PubMed

Evidence Snippets

The eye has a complex and metabolically active neurovascular system.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1review2022International Journal of Molecular SciencesDOI PubMed

1 evidence snippet 5 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1disease associationsupports2022Source 1DOI PubMed

Vascular complications including insufficient blood supply and blood-retinal barrier disruption have been suggested to contribute to glaucoma, age-related macular degeneration, and Alzheimer's disease, resulting in neuronal cell death.

Claim 2mechanistic associationsupports2022Source 1DOI PubMed

Damage to ocular blood vessels is associated with blood-retinal barrier disruption, altered cellular communication, disrupted mitochondrial function, and exacerbated aggregated protein accumulation.

Claim 3pathophysiology outcomesupports2022Source 1DOI PubMed

Neuronal loss can induce vision loss in aging-related eye disease contexts discussed in the review.

Claim 4review summarysupports2022Source 1DOI PubMed

Repeated light injuries induce aging and trigger age-dependent eye diseases.

Claim 5therapeutic directionsupports2022Source 1DOI PubMed

Beneficial molecular pathways to prevent or slow retinal pathologic processes are discussed as a therapeutic direction in aging-related eye disease.